Charles A Baker - Net Worth and Insider Trading
Charles A Baker Net Worth
The estimated net worth of Charles A Baker is at least $8 Million dollars as of 2024-04-19. Charles A Baker is the Director of Regeneron Pharmaceuticals Inc and owns about 9,000 shares of Regeneron Pharmaceuticals Inc (REGN) stock worth over $8 Million. Details can be seen in Charles A Baker's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Charles A Baker has not made any transactions after 2017-09-29 and currently still holds the listed stock(s).
Transaction Summary of Charles A Baker
Charles A Baker Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Charles A Baker owns 2 companies in total, including Regeneron Pharmaceuticals Inc () , and Progenics Pharmaceuticals Inc () .
Click here to see the complete history of Charles A Baker’s form 4 insider trades.
Insider Ownership Summary of Charles A Baker
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc | 2017-09-29 | director | |
| Progenics Pharmaceuticals Inc | 2012-06-13 | director |
Charles A Baker Latest Holdings Summary
Charles A Baker currently owns a total of 1 stock. Charles A Baker owns 9,000 shares of Regeneron Pharmaceuticals Inc (REGN) as of September 29, 2017, with a value of $8 Million.
Latest Holdings of Charles A Baker
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| REGN | Regeneron Pharmaceuticals Inc | 2017-09-29 | 9,000 | 896.82 | 8,071,380 |
Holding Weightings of Charles A Baker
Charles A Baker Form 4 Trading Tracker
According to the SEC Form 4 filings, Charles A Baker has made a total of 0 transactions in Regeneron Pharmaceuticals Inc (REGN) over the past 5 years. The most-recent trade in Regeneron Pharmaceuticals Inc is the sale of 2,000 shares on September 29, 2017, which brought Charles A Baker around $900,000.
Insider Trading History of Charles A Baker
- 1
Charles A Baker Trading Performance
Charles A Baker Ownership Network
Ownership Network List of Charles A Baker
Ownership Network Relation of Charles A Baker
Charles A Baker Owned Company Details
What does Regeneron Pharmaceuticals Inc do?
Who are the key executives at Regeneron Pharmaceuticals Inc?
Charles A Baker is the director of Regeneron Pharmaceuticals Inc. Other key executives at Regeneron Pharmaceuticals Inc include SVP Commercial Marion Mccourt , EVP Research Andrew J Murphy , and SVP Gen Counsel & Secretary Joseph J Larosa .
Regeneron Pharmaceuticals Inc () Insider Trades Summary
Over the past 18 months, Charles A Baker made no insider transaction in Regeneron Pharmaceuticals Inc (). Other recent insider transactions involving Regeneron Pharmaceuticals Inc () include a net sale of 10,816 shares made by Marion Mccourt , a net sale of 1,300 shares made by Arthur F Ryan , and a net sale of 7,302 shares made by Bonnie L Bassler .
In summary, during the past 3 months, insiders sold 43,969 shares of Regeneron Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 43,969 shares. During the past 18 months, 198,549 shares of Regeneron Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 198,549 shares.
Regeneron Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Regeneron Pharmaceuticals Inc Insider Transactions
Charles A Baker Mailing Address
Above is the net worth, insider trading, and ownership report for Charles A Baker. You might contact Charles A Baker via mailing address: 777 Old Saw Mill River Road, Tarrytown Ny 10591.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
